Skip to content
healthcare.dev

DILTIAZEM HYDROCHLORIDE

NDC 69097-997, diltiazem hydrochloride, tablet, extended release, from Cipla USA, Inc..

Product NDC
69097-997
Status
Listed
Labeler
Cipla USA, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216327
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-997 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DILTIAZEM HYDROCHLORIDE420 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
69097-997-026909709970230 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-997-02)
69097-997-056909709970590 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-997-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bce61158-201d-458c-be0c-9bdd2d3a0bec
  • NADAC price for package 69097099702

    GET /v1/drugs/nadac/69097099702
  • NADAC price for package 69097099705

    GET /v1/drugs/nadac/69097099705

Use it

Look up 69097-997 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-997 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-997. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.